In the US, PrandiMet (metformin/repaglinide systemic) is a member of the drug class antidiabetic combinations and is used to treat Diabetes, Type 2.
US matches:
- PrandiMet
Ingredient matches for PrandiMet
Metformin
Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of PrandiMet in the following countries:
- United States
Pioglitazone
Pioglitazone hydrochloride (a derivative of Pioglitazone) is reported as an ingredient of PrandiMet in the following countries:
- United States
International Drug Name Search
No comments:
Post a Comment